CLINICAL MANAGEMENT GUIDELINE

Community acquired pneumonia

ICD10: Unspecified bacterial pneumonia [J15.9]

Treatment: Empirical antibiotics for hospitalized patient

Hospital admission is recommended in the following situations:

Patients with a PSI score of 71-90 (class III), who may benefit from a brief period of hospitalization. Patients with PSI class IV or class V pneumonia (who have a 9% and a 27% risk of death, respectively) Patients with a CURB-65 score of ≥3, who should be hospitalized, and those with a score of 4 or 5 (with predicted mortality rates of 15% to 40%, respectively), who should be considered for ICU admission.


Activate this plan as soon as possible before laboratory results 1

This plan is predominantly targeting the most common bacterial pathogens; Streptococcus pneumonia, Haemophilus influenza, the common atypical bacteria (Mycoplasma pneumonia, Chlamydia pneumoniae, and Legionella spp). Gram-negative bacilli (Enterobacteriaceae and Pseudomonas aeruginosa).

Treatments

Level 1 / 2
pharmacological
Cefotaxime
ROUTE
IV
DOSE
1.000 g
FREQUENCY
Q8hr
pharmacological
ertapenem
ROUTE
IV
DOSE
1.000 g
FREQUENCY
OD
pharmacological
Ampicillin
ROUTE
IV
DOSE
1.500 g
FREQUENCY
Q6hr
pharmacological
Doxycycline
ROUTE
IV
DOSE
100.000 mg
FREQUENCY
Q12hr
pharmacological
Azithromycin
ROUTE
IV
DOSE
500.000 mg
FREQUENCY
OD

View complete treatment plan

Access complete guideline of Community acquired pneumonia (Adult) now,
with powerful features to assist you for making better clinical management decision

  • Duplicating mechanism of action of effect
  • Weight based dosing
  • Contraindication
  • Renal dosing
  • Interactions to drugs or diseases
  • Hepatic dosing

And more...